Erratum: Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients (Cell Research (2015) 25 (1250-1264)) DOI: 10.1038/cr.2015.126);Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients

Cell Research

Volumn 25, Issue 11, 2015, Pages 1250-1264

  Wen, Lu ^a   Li, Jingyi ^a   Guo, Huahu ^a,b   Liu, Xiaomeng ^a   Zheng, Shengmin ^c   Zhang, Dafang ^c   Zhu, Weihua ^c   Qu, Jianhui ^d   Guo, Limin ^e   Du, Dexiao ^a,b   Jin, Xiao ^a   Zhang, Yuhao ^a   Gao, Yun ^a   Shen, Jie ^a   Ge, Hao ^a   Tang, Fuchou ^a   Huang, Yanyi ^a   Peng, Jirun ^a,b  

^a PEKING UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d BEIJING 302 HOSPITAL   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

circulating cell free DNA; DNA methylation; hepatocellular carcinoma; next generation sequencing

Indexed keywords

DNA;

BLOOD; CARCINOMA, HEPATOCELLULAR; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENETICS; HUMAN; LIVER NEOPLASMS; MOLECULAR PATHOLOGY; NUCLEIC ACID AMPLIFICATION; PROCEDURES;

CARCINOMA, HEPATOCELLULAR; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; HUMANS; LIVER NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PATHOLOGY, MOLECULAR; SEQUENCE ANALYSIS, DNA;

EID: 84946488414     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.141     Document Type: Erratum

References (25)

1. Baylin SB, Jones PA. A decade of exploring the cancer epigenome -biological and translational implications. Nat Rev Cancer 2011; 11: 726-734
2. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153
3. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 2014; 342: 223-230
4. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-437
5. Wong IH, Lo YM, Zhang J, et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999; 59: 71-73
6. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010; 11: 191-203
7. Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16: 383-393
8. Meissner A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454: 766-770
9. Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc 2011; 6: 468-481
10. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108
11. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022
12. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010; 16: 418-424
13. Kivioja T, Vaharautio A, Karlsson K, et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods 2012; 9: 72-74
14. Li M, Chen WD, Papadopoulos N, et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009; 27: 858-863
15. Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008; 54: 414-423
16. Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 2011; 9: 133
17. Lusis EA, Watson MA, Chicoine MR, et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 2005; 65: 7121-7126
18. Patra SK, Szyf M. DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A. FEBS J 2008; 275: 5217-5235
19. Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009; 9: 773-784
20. Illingworth R, Kerr A, Desousa D, et al. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008; 6: e22
21. Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One 2013; 8: e55761
22. TCGA Data Portal Overview. Available at https://tcga-data. nci.nih.gov/tcga/tcgaHome2.jsp
23. Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med 2014; 6: 224ra24
24. Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 2014; 147: 765-783
25. Sproul D, Kitchen RR, Nestor CE, et al. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 2012; 13: R84